Hepatocellular Carcinoma Clinical Trials in Grenoble
4 recruitingGrenoble, France
Showing 1–4 of 4 trials
Recruiting
Not Applicable
Identification of Innovative Biomarkers to Predict Outcomes in Hepatocellular Carcinoma Treated With Tremelimumab and Durvalumab
Hepatocellular Carcinoma
Centre Hospitalier Universitaire de Besancon120 enrolled10 locationsNCT06796114
Recruiting
Phase 2
Neoadjuvant Atezo, Adjuvant Atezo + Beva Combined With RF Ablation of Small HCC: a Multicenter Randomized Phase II Trial
Hepatocellular Carcinoma
University Hospital, Montpellier202 enrolled19 locationsNCT04727307
Recruiting
Phase 3
Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO
Triple-Negative Breast CancerCervical CancerUrothelial Carcinoma+12 more
UNICANCER646 enrolled40 locationsNCT05078047
Recruiting
Phase 3
The ABC-HCC Trial: Atezolizumab Plus Bevacizumab vs. Transarterial Chemoembolization (TACE) in Intermediate-stage HepatoCellular Carcinoma
Hepatocellular Carcinoma
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest434 enrolled72 locationsNCT04803994